Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label trial of posaconazole and benznidazole for chronic Chagas disease
2009-017467-42Phase 2Completed
- Sponsor
- Servicio de Enfermedades Infecciosas
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in American trypanosomiasis (CD) comparing Posaconazole with Benznidazole (2 arms). Primary endpoints: Parasitological cure at 10 months after treatment and Serial real-time PCR assessments. Started Feb 2010; status: completed.
02
Drugs
posaconazolebenznidazole
03
Conditions
American trypanosomiasis (CD)
Beyond the preview
Go deeper on 2009-017467-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017467-42.